AI assistant
Sending…
Qualigen Therapeutics, Inc. — Director's Dealing 2017
Oct 23, 2017
35251_dirs_2017-10-23_231563e5-ddf9-493c-8843-27b9e63fe290.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-10-12
Reporting Person: Benjamin Jeffrey S (VP of Finance)
More from Qualigen Therapeutics, Inc.
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Feb 27
Board/Management Information
2026
Feb 17
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 29
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 6
Audit Report / Information
2025
Dec 16
Proxy Solicitation & Information Statement
2025
Dec 15